BK Virus in Hematopoietic Stem Cell Transplantation Recipients

Amy Federoff

stem cell transplantation, oncologic emergency, hematopoietic cell transplantation, hematopoietic stem cell transplantation
CJON 2008, 12(6), 895-900. DOI: 10.1188/08.CJON.895-900

BK virus has become a serious issue in hematopoietic stem cell transplantation recipients, commonly manifesting as hemorrhagic cystitis, which can last from a matter of days to months and, if severe enough, may result in death. Patients with BK virus-associated hemorrhagic cystitis often experience poor quality of life, severe pain and discomfort, and prolonged hospitalizations. Despite numerous advances in stem cell transplantation methods, BK virus-associated hemorrhagic cystitis is difficult to control and treatment options are few. This article provides an overview of BK virus along with risk factors, current treatment modalities, and nursing considerations.

Jump to a section


    Andrews, C. A., Shah, K. V., Daniel, R. W., Hirsch, M. S., & Rubin, R. H. (1988). A serological investigation of BK and JC virus infections in allograft recipients. Journal of Infectious Disease, 158(1), 176-181.
    Azzi, A., Cessaro, S., Laszlo, D., Zakrzewska, K., Ciappi, S., De Santis, R., et al. (1999). Human polyoma BK load and hemorrhagic cystitis. Journal of Clinical Virology, 14(2), 79-86.
    Bedi, A., Miller, C. B., Hanson, J. L., Goodman, S., Ambinder, R. F., Charache, P., et al. (1995). Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following BMT. Journal of Clinical Oncology, 13(5), 1103-1109.
    Bogdanovic, G., Priftakis, P., Giraud, G., & Dallianis, T. (2006). A related donor and reduced intensity conditioning reduces the risk of development of BK virus-positive haemorrhagic cystitis in allogenic haematopoetic stem cell-transplanted patients. Anticancer Research, 26(2B), 1311-1318.
    Bogdanovic, G., Priftakis, P., Giraud, G., Kuzniar, M., Ferraldeschi, R., Kokhaei, P., et al. (2004). Association between a high BK virus load in urine samples of patients with GVHD and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. Journal of Clinical Microbiology, 42(11), 5394-5396.
    Chesters, P. M., Hentage, J., & McCance, D. J. (1983). Persistence of DNA sequences of BK virus and JC virus in normal human tissues and diseased tissues. Journal of Infectious Diseases, 147(4), 676-684.
    Demesmay, K., Tissot, E., Bulabois, C. E., Bertrand, M. A., Racadot, E., Woronoff-Lemsi, M. C. (2002). Factor VIII replacement in stem cell transplant recipients with severe hemorrhagic cystitis: A report of four cases. Transplantation, 74(8), 1190-1192.
    Dolei, A., Pietropolo, V., Gomes, E., Di Taranto, C., Ziccheddu, M., Spanu, M. A., et al. (2000). Polyomavirus persistance in lymphocytes: Prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion center. Journal of General Virology, 81(Pt. 8), 1967-1973.
    El-Zimaity, M., Saliba, R., Chan, K., Shahjahan, M., Carrasco, A., Khorshid, O., et al. (2004). Hemorrhagic cystitis after allogenic hematopoietic stem cell transplantation: Donor type matters. Blood, 12(103), 4674-4680.
    Erard, V., Hyung, W. K., Corey, L., Limaye, A., Huang, M. L., Davis, C., et al. (2005). BK DNA viral load in plasma: Evidence for an association with hemorrhagic cystitis in allogenic hematopoietic stem cell transplant recipients. Blood, 106(3), 1130-1131.
    Erard, V., Storer, B., Lawrence, C., Nollcamper, J., Huang, M. L., Limaye, A., et al. (2004). BK virus infection in hematopoietic stem cell transplant recipients: Frequency, risk factors, and association with post engraftment hemorrhagic cystitis. Clinical Infectious Diseases, 39(12), 1861-1865.
    Galan, A., Rauch, C., & Otis, C. (2005). Fatal BK polyoma viral pneumonia associated with immunosuppression. Human Pathology, 9(36), 1031-1034.
    Giraud, G., Bogdanovic, G., & Priftakis, P. (2006). The incidence of hemorrhagic cystitis and BK viruira in allogenic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Hematology Journal, 91(3), 401-404.
    Goudsmit, J., Wertheim-van Dillen, P., van Strien, A., & van der Noorda, J. (1982). The role of BK virus in acute respiratory tract disease and the presence of BK virus DNA in tonsils. Journal of Medical Virology, 10(2), 91-99.
    Haselberger, M. B., & Schwinghammer, T. L. (1995). Efficacy of mesna for prevention of hemorrhagic cystitis after high dose cyclophosphamide therapy. Annals of Pharmacotherapy, 29(9), 918-921.
    Hattori, K., Yabe, M., Matsumoto, M., Kudo, Y., Yasuda, Y., Inoue, H., et al. (2001). Case report: Successful hyperbaric oxygen treatment of life threatening hemorrhagic cystitis. Bone Marrow Transplantation, 27(12), 1315-1317.
    Hirsch, H. H. (2002). Polyomavirus BK nephropathy: A (re-)emerging complication in renal transplantation. American Journal of Transplantation, 2(1), 25-30
    Hirsch, H. H., & Steiger, J. (2003). Polyoma virus BK. Lancet Infectious Disease, 3(10), 611-623.
    Jacobsohn, D. A., & Vogelsang, G. B. (2007). Acute graft versus host disease. Orphanet Journal of Rare Diseases, 2, 35.
    Knowles, W. A. (2001). The epidemiology of BK virus and the occurrence of antigenic and genomic subtypes. In K. Khalili, & G. L. Stoner (Eds.), Human polyoma viruses: Molecular and clinical perspectives (pp. 527-559). New York: Wiley-Liss.
    Koc, S., Hagglund, H., Ireton, R. C., Perez-Simon, J. A., Collins, S. J., & Appelbaum, F. R. (2000). Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogenic hematopoietic cell transplantation. Bone Marrow Transplantation, 26(8), 899-901.
    Lakhani, A., Raptis, A., & Frame, D. (1999). Intravesicular instillation of E-aminocaproic for patients with adeno-virus induced hemorrhagic cystitis. Bone Marrow Transplantation, 24(11), 1259-1260.
    Leung, A. Y., Chan, M. T., Yuen, K. Y., Cheng, V. C., Chan, K. H., Kwong, Y. L., et al. (2005). Ciprofloxacin decreased polyoma BK viruria in patients undergoing allogenic hematopoietic stem cell transplantation. Clinical Infectious Diseases, 40(4), 528-537.
    Leung, A. Y., Mak, R., Lie, A. K., Yuen, K. Y., Cheng, V. C., Liang, R., et al. (2002). Clinicopathological features and risk factors of clinically overt hemorrhagic cystitis complicating bone marrow transplant. Bone Marrow Transplantation, 29(6), 509-513.
    Leung, A. Y., Suen, C. K., Lie, A. K., Liang, R. H., Yuen, K. Y., & Kwong, Y. L. (2001). Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplant. Blood, 98(6), 1971-1978.
    Leung, A. Y., Yuen, K. Y., & Kwong, Y. L. (2005). Polyoma BK virus and hemorrhagic cystitis in hematopoietic stem cell transplantation. Bone Marrow Transplantation, 36(11), 929-937.
    Schuchter, L. M., Hensley, M. L., Meropol, N. J., & Winer, E. P. (2002). Update of recommendations for the use of chemotherapy and radiotherapy protectants: Clinical Practice Guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology, 20(12), 2895-2903.
    Seabra, C., Perez-Simon, J., Sierra, M., Marcos, J. M., Caballero, M. D., de la Loma, A., et al. (2000). Case report: Intramuscular vidarabine therapy for polyoma virus associated hemorrhagic cystitis following allogenic stem cell transplantation. Bone Marrow Transplantation, 26(11), 1229-1230.
    Seber, A., Shu, X. O., Defor, T., Sencer, S., & Ramsey, N. (1999). Risk factors for severe hemorrhagic cystitis following BMT. Bone Marrow Transplantation, 23(1), 35-40.
    Sencer, S. F., Haake, R. J., & Weisdorf, D. J. (1993). Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications. Transplantation, 56(4), 875-879.
    Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., et al. (1998). Nonmyeloblative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cyto-reduction for the treatment of malignant and non-malignant hematologic diseases. Blood, 91(3), 756-763.
    Srivastava, A., Nair, S., Srivastava, V., Balamurugan, A. N., Jeyaseelan, L., Chandy, M., et al. (1999). Evaluation of uroprotective efficacy of amifostine against cyclophosphamide induced hemorrhagic cystitis. Bone Marrow Transplantation, 23(5), 463-467.
    Sundsfjord, A., Spein, A. R., Lucht, E., Flaegstad, T., Seternes, O. M., & Traavik, T. (1994). Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients. Journal of Clinical Microbiology, 32(5), 1390-1394.
    Wong, A., Chan, K., Cheung, V., Yuen, K. Y., Kwong, Y. L., & Leung, A. Y. (2007). Relationship of pre-transplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clinical Infectious Disease, 44(6), 830-837.
    Yamamoto, R., Kusmi, E., & Kami, M. (2003). Late hemorrhagic cystitis after reduced intensity hematopoietic stem cell transplant. Bone Marrow Transplantation, 11(32), 1089-1095.